140 related articles for article (PubMed ID: 21934714)
1. Involvement of surfactant protein D in emphysema revealed by genetic association study.
Ishii T; Hagiwara K; Kamio K; Ikeda S; Arai T; Mieno MN; Kumasaka T; Muramatsu M; Sawabe M; Gemma A; Kida K
Eur J Hum Genet; 2012 Feb; 20(2):230-5. PubMed ID: 21934714
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in surfactant protein-D are associated with chronic obstructive pulmonary disease.
Foreman MG; Kong X; DeMeo DL; Pillai SG; Hersh CP; Bakke P; Gulsvik A; Lomas DA; Litonjua AA; Shapiro SD; Tal-Singer R; Silverman EK
Am J Respir Cell Mol Biol; 2011 Mar; 44(3):316-22. PubMed ID: 20448057
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of surfactant protein D rs2243639, Interleukin (IL)-1β rs16944 and IL-1RN rs2234663 in chronic obstructive pulmonary disease, healthy smokers, and non-smokers.
Issac MS; Ashur W; Mousa H
Mol Diagn Ther; 2014 Jun; 18(3):343-54. PubMed ID: 24504887
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced.
Heidinger K; König IR; Bohnert A; Kleinsteiber A; Hilgendorff A; Gortner L; Ziegler A; Chakraborty T; Bein G
Immunogenetics; 2005 Apr; 57(1-2):1-7. PubMed ID: 15700120
[TBL] [Abstract][Full Text] [Related]
5. Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD.
Kim WJ; Hoffman E; Reilly J; Hersh C; Demeo D; Washko G; Silverman EK
Eur Respir J; 2011 Jan; 37(1):39-43. PubMed ID: 20525719
[TBL] [Abstract][Full Text] [Related]
6. The association of Toll-like receptor 4 gene polymorphisms with the development of emphysema in Japanese subjects: a case control study.
Ito M; Hanaoka M; Droma Y; Kobayashi N; Yasuo M; Kitaguchi Y; Horiuchi T; Ikegawa K; Katsuyama Y; Kubo K; Ota M
BMC Res Notes; 2012 Jan; 5():36. PubMed ID: 22251849
[TBL] [Abstract][Full Text] [Related]
7. Association between genetic variations in surfactant protein d and emphysema, interstitial pneumonia, and lung cancer in a Japanese population.
Ishii T; Hagiwara K; Ikeda S; Arai T; Mieno MN; Kumasaka T; Muramatsu M; Sawabe M; Gemma A; Kida K
COPD; 2012 Aug; 9(4):409-16. PubMed ID: 22509983
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of pulmonary SP-D predict disease outcome of COPD in a Chinese population.
Ou CY; Chen CZ; Hsiue TR; Lin SH; Wang JY
Respirology; 2015 Feb; 20(2):296-303. PubMed ID: 25376584
[TBL] [Abstract][Full Text] [Related]
9. Association between the surfactant protein D (SFTPD) gene and subclinical carotid artery atherosclerosis.
Sorensen GL; Bladbjerg EM; Steffensen R; Tan Q; Madsen J; Drivsholm T; Holmskov U
Atherosclerosis; 2016 Mar; 246():7-12. PubMed ID: 26748346
[TBL] [Abstract][Full Text] [Related]
10. Surfactant protein-D-encoding gene variant polymorphisms are linked to respiratory outcome in premature infants.
Sorensen GL; Dahl M; Tan Q; Bendixen C; Holmskov U; Husby S
J Pediatr; 2014 Oct; 165(4):683-9. PubMed ID: 25015576
[TBL] [Abstract][Full Text] [Related]
11. Differences in serum SP-D levels between German and Japanese subjects are associated with SFTPD gene polymorphisms.
Horimasu Y; Hattori N; Ishikawa N; Tanaka S; Bonella F; Ohshimo S; Guzman J; Costabel U; Kohno N
BMC Med Genet; 2014 Jan; 15():4. PubMed ID: 24400879
[TBL] [Abstract][Full Text] [Related]
12. Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.
Sun W; Kechris K; Jacobson S; Drummond MB; Hawkins GA; Yang J; Chen TH; Quibrera PM; Anderson W; Barr RG; Basta PV; Bleecker ER; Beaty T; Casaburi R; Castaldi P; Cho MH; Comellas A; Crapo JD; Criner G; Demeo D; Christenson SA; Couper DJ; Curtis JL; Doerschuk CM; Freeman CM; Gouskova NA; Han MK; Hanania NA; Hansel NN; Hersh CP; Hoffman EA; Kaner RJ; Kanner RE; Kleerup EC; Lutz S; Martinez FJ; Meyers DA; Peters SP; Regan EA; Rennard SI; Scholand MB; Silverman EK; Woodruff PG; O'Neal WK; Bowler RP; ;
PLoS Genet; 2016 Aug; 12(8):e1006011. PubMed ID: 27532455
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease.
Kim DK; Cho MH; Hersh CP; Lomas DA; Miller BE; Kong X; Bakke P; Gulsvik A; Agustí A; Wouters E; Celli B; Coxson H; Vestbo J; MacNee W; Yates JC; Rennard S; Litonjua A; Qiu W; Beaty TH; Crapo JD; Riley JH; Tal-Singer R; Silverman EK;
Am J Respir Crit Care Med; 2012 Dec; 186(12):1238-47. PubMed ID: 23144326
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variants in IL6R and ADAM19 are Associated with COPD Severity in a Mexican Mestizo Population.
Pérez-Rubio G; Silva-Zolezzi I; Fernández-López JC; Camarena Á; Velázquez-Uncal M; Morales-Mandujano F; Hernández-Zenteno Rde J; Flores-Trujillo F; Sánchez-Romero C; Velázquez-Montero A; Espinosa de Los Monteros C; Sansores RH; Ramírez-Venegas A; Falfán-Valencia R
COPD; 2016 Oct; 13(5):610-5. PubMed ID: 27078193
[TBL] [Abstract][Full Text] [Related]
15. Influence of genetic variability at the surfactant proteins A and D in community-acquired pneumonia: a prospective, observational, genetic study.
García-Laorden MI; Rodríguez de Castro F; Solé-Violán J; Rajas O; Blanquer J; Borderías L; Aspa J; Briones ML; Saavedra P; Marcos-Ramos JA; González-Quevedo N; Sologuren I; Herrera-Ramos E; Ferrer JM; Rello J; Rodríguez-Gallego C
Crit Care; 2011; 15(1):R57. PubMed ID: 21310059
[TBL] [Abstract][Full Text] [Related]
16. SP-D polymorphisms and the risk of COPD.
Shakoori TA; Sin DD; Bokhari SN; Ghafoor F; Shakoori AR
Dis Markers; 2012; 33(2):91-100. PubMed ID: 22846212
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Meta-Analysis Confirms Significant Contribution of Surfactant Protein D in Chronic Obstructive Pulmonary Disease.
Nandy D; Sharma N; Senapati S
Front Genet; 2019; 10():339. PubMed ID: 31057601
[No Abstract] [Full Text] [Related]
18. Genetic Association With
Nourkami-Tutdibi N; Freitag K; Zemlin M; Tutdibi E
Front Immunol; 2021; 12():587313. PubMed ID: 33679736
[No Abstract] [Full Text] [Related]
19. Polymorphisms in the superoxide dismutase-3 gene are associated with emphysema in COPD.
Sørheim IC; DeMeo DL; Washko G; Litonjua A; Sparrow D; Bowler R; Bakke P; Pillai SG; Coxson HO; Lomas DA; Silverman EK; Hersh CP;
COPD; 2010 Aug; 7(4):262-8. PubMed ID: 20673035
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema.
Ito I; Nagai S; Handa T; Muro S; Hirai T; Tsukino M; Mishima M
Am J Respir Crit Care Med; 2005 Dec; 172(11):1378-82. PubMed ID: 16126934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
